tiprankstipranks
Advertisement
Advertisement

REGN Stock Latest News

Regeneron Buy Rating Reiterated on Robust Pipeline and Capital Discipline; $968 Price Target Unchanged
RatingsRegeneron Buy Rating Reiterated on Robust Pipeline and Capital Discipline; $968 Price Target Unchanged
6h ago
REGN
Regeneron, Sanofi present results from Dupixent Phase 4 trial
PremiumThe Fly
Regeneron, Sanofi present results from Dupixent Phase 4 trial
6h ago
SNY
REGN
Regeneron price target raised to $995 from $975 at Guggenheim
PremiumThe Fly
Regeneron price target raised to $995 from $975 at Guggenheim
4d ago
REGN
Regeneron: Earnings Strength and Pipeline Optionality Support Buy Rating as 12-Month Price Target Ticks Up to $968
PremiumRatings
Regeneron: Earnings Strength and Pipeline Optionality Support Buy Rating as 12-Month Price Target Ticks Up to $968
4d ago
REGN
Regeneron price target lowered to $788 from $796 at Morgan Stanley
PremiumThe Fly
Regeneron price target lowered to $788 from $796 at Morgan Stanley
5d ago
REGN
Regeneron price target lowered to $796 from $801 at Truist
PremiumThe FlyRegeneron price target lowered to $796 from $801 at Truist
5d ago
REGN
Regeneron price target lowered to $762 from $779 at RBC Capital
Premium
The Fly
Regeneron price target lowered to $762 from $779 at RBC Capital
5d ago
SNY
REGN
Regeneron: Buy Rating Reiterated as Analyst Sees Melanoma Trial Sell-Off Overdone; $900 Price Target Unchanged
Premium
Ratings
Regeneron: Buy Rating Reiterated as Analyst Sees Melanoma Trial Sell-Off Overdone; $900 Price Target Unchanged
5d ago
REGN
Regeneron price target lowered to $917 from $923 at Barclays
PremiumThe Fly
Regeneron price target lowered to $917 from $923 at Barclays
5d ago
REGN
Regeneron Earnings Call Highlights Durable Growth Engine
PremiumCompany Announcements
Regeneron Earnings Call Highlights Durable Growth Engine
6d ago
REGN
These Are the Stocks Reporting Earnings Today – April 29, 2026
PremiumMarket News
These Are the Stocks Reporting Earnings Today – April 29, 2026
6d ago
F
GD
Morning Movers: NXP Semi, Bloom Energy charged up after results
PremiumThe Fly
Morning Movers: NXP Semi, Bloom Energy charged up after results
6d ago
BE
GD
Regeneron reports Q1 adjusted EPS $9.47, consensus $8.90
PremiumThe FlyRegeneron reports Q1 adjusted EPS $9.47, consensus $8.90
6d ago
REGN
Regeneron announces new $3B share repurchase program
Premium
The Fly
Regeneron announces new $3B share repurchase program
6d ago
REGN
Notable companies reporting before tomorrow’s open
Premium
The Fly
Notable companies reporting before tomorrow’s open
7d ago
GD
CAR
Regeneron Pharmaceuticals (REGN) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Regeneron Pharmaceuticals (REGN) Q1 Earnings Cheat Sheet
8d ago
REGN
Regeneron announces agreement with U.S. government to help lower drug costs
PremiumThe Fly
Regeneron announces agreement with U.S. government to help lower drug costs
12d ago
REGN
FDA grants accelerated approval for Regeneron’s Otarmeni
PremiumThe Fly
FDA grants accelerated approval for Regeneron’s Otarmeni
12d ago
REGN
Regeneron agrees to lower prices as gene therapy approved, Bloomberg says
PremiumThe Fly
Regeneron agrees to lower prices as gene therapy approved, Bloomberg says
12d ago
REGN
Regeneron price target raised to $960 from $880 at TD Cowen
PremiumThe FlyRegeneron price target raised to $960 from $880 at TD Cowen
12d ago
REGN
Regeneron, Sanofi: FDA approves Dupixent for treatment of CSU in ages 2-11
Premium
The Fly
Regeneron, Sanofi: FDA approves Dupixent for treatment of CSU in ages 2-11
13d ago
SNY
REGN
Regeneron announces publication of Phase 3 NIMBLE trial results
Premium
The Fly
Regeneron announces publication of Phase 3 NIMBLE trial results
14d ago
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >